Adam Matkowski

Dr. Adam Matkowski

Pharmaceutical Biology and Biotechnology, Wroclaw Medical University, Wrocław, Dolnośląskie, Poland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Biotechnology Advances
Verified
Journal Article
Closed access
Adam MatkowskiAdam Matkowski
Adam Matkowski

1 June 2019 in Phytochemistry
Verified
Journal Article
Closed access
SGShima Gharibi
Shima Gharibi
BTBadraldin Ebrahim Sayed Tabatabaei
Badraldin Ebrahim Sayed Tabatabaei
GSGhodratolah Saeidi
Ghodratolah Saeidi
MTMajid Talebi
Majid Talebi
Adam MatkowskiAdam Matkowski
Adam Matkowski

Verified
Journal Article
Open access
PDF file
Zdenek KejikZdenek Kejik
Zdenek Kejik
RKRobert Kaplánek
Robert Kaplánek
MMMichal Masařík
Michal Masařík
PBPetr Babula
Petr Babula
Adam MatkowskiAdam Matkowski
Adam Matkowski
Milan JakubekMilan Jakubek
Milan Jakubek
Flavonoids are common plant natural products able to suppress ROS-related damage and alleviate oxidative stress. One of key mechanisms, involved in this phenomenon is chelation of transition metal ions. From a physiological perspective, iron is the most significant transition metal, because of its abundance in living organisms and ubiquitous involvement in redox processes. The chemical, pharmaceutical, and biological properties of flavonoids can be significantly affected by their interaction with transition metal ions, mainly iron. In this review, we explain the interaction of various flavonoid structures with Fe(II) and Fe(III) ions and critically discuss the influence of chelated ions on the flavonoid biochemical properties. In addition, specific biological effects of their iron metallocomplexes, such as the inhibition of iron-containing enzymes, have been included in this review.

1 January 2007 in Food Chemistry
Verified
Journal Article
Closed access
IGIzabela Grzegorczyk-Karolak
Izabela Grzegorczyk-Karolak
Adam MatkowskiAdam Matkowski
Adam Matkowski
HWH. Wysokińska
H. Wysokińska

3 April 2014 in Phytochemistry Reviews
Verified
Journal Article
Open access
PDF file
SZSylwia Zielinska
Sylwia Zielinska
Adam MatkowskiAdam Matkowski
Adam Matkowski
Agastache is a small genus of Lamiaceae, comprising 22 species of perennial aromatic medicinal herbs. In this article, we review recent advances in phytochemical, pharmacological, biotechnological and molecular research on Agastache. The phytochemical profile of all Agastache species studied to date is generally similar, consisted of two main metabolic classes—phenylpropanoids and terpenoids. In the relatively variable essential oils, most populations of different Agastache species contain over 50 % of a phenylallyl compound—estragole. Also, other volatile compounds (methyleugenol, pulegone, menthone, isomenthone and spathulenol) were reported in various proportions. Major non-volatile metabolites belong to phenolic compounds, such as caffeic acid derivatives, especially rosmarinic acid as well as several flavones and flavone glycosides like acacetin, tilianin, agastachoside, and a rare dimeric malonyl flavone (agastachin). Two unique lignans—agastenol and agastinol—were also isolated. Terpenoids include triterpenoids of oleanane-type (maslinic acid, oleanolic acid and β-amyrin), ursane-type (ursolic acid, corosolic acid and α-amyrin), and typical plant sterols, as well as abietane-type oxidized diterpenes (e.g., agastaquinone, agastol, and others). The bioactivity of various extracts or individual compounds in vitro and in vivo include antimicrobial, antiviral and anti-mutagenic activity, cytotoxic activity to cancer cell lines, and anti-nociceptive, anti-inflammatory, anti-atherogenic, antioxidant as well as biocidal activity to several foodstuff pests. Biotechnological and molecular studies have focused on in vitro propagation and enhancing the biosynthesis of bioactive metabolites in cell or organ cultures, as well as on the expression of genes involved in phenolic biosynthesis.

1 July 2006 in Fitoterapia
Verified
Journal Article
Closed access
Adam MatkowskiAdam Matkowski
Adam Matkowski
MPMagdalena Piotrowska
Magdalena Piotrowska